Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins

The interaction of cinoxacin (CINX), nalidixic acid (NA), and pipemidic acid (PPA) with human and rat serum albumins (HSA and RSA) was studied by UV difference absorption and circular dichroism (CD) spectroscopy. CINX and NA bound to the albumins and generated difference absorption and induced CD (I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemical & pharmaceutical bulletin 1989/03/25, Vol.37(3), pp.746-752
Hauptverfasser: IZUMI, Taro, NAGAYAMA, Takako, KITAGAWA, Takayasu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 752
container_issue 3
container_start_page 746
container_title Chemical & pharmaceutical bulletin
container_volume 37
creator IZUMI, Taro
NAGAYAMA, Takako
KITAGAWA, Takayasu
description The interaction of cinoxacin (CINX), nalidixic acid (NA), and pipemidic acid (PPA) with human and rat serum albumins (HSA and RSA) was studied by UV difference absorption and circular dichroism (CD) spectroscopy. CINX and NA bound to the albumins and generated difference absorption and induced CD (ICD) spectra. The difference absorption spectral data explained reasonably our previous observations that CINX bound to HSA more weakly than NA, but to RSA as strongly as NA. We used a quantity Δε/ε, designated as relative molar difference absorbance, at positions corresponding to the longest wavelength peaks in the difference spectra. The quantity was found to correlate linearly with percent bound to both HSA and RSA, but with different slopes, from which the binding site for CINX and NA in RSA was supposed to provide a much more nonpolar environment than that in HSA. The magnitude of ICD bands observed at 371 nm for CINX and at 342-348 nm for NA corresponded to the binding degrees of these drugs to both albumins. Anisotropy factors for the ICD bands at 350-271 nm for CINX and 320-348 nm for NA were approximately similar between HSA and RSA, suggesting a similar ability to generate the ICD spectra in these wavelength regions upon binding to the albumins. Spectral results for PPA in albumin solutions showed little or no binding of this drug to HSA and RSA. PPA existed as a betaine form in neutral solution and its positively charged group acted as an unfavorable factor for binding to both albumins.
doi_str_mv 10.1248/cpb.37.746
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79104063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79104063</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4496-b7d4a247c2a92fee2278c78f5359344e052d9ec0b8103b9e06d383fbd6553a5b3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSMEKtPChj2SN7BAZHD8EyfshqjQkSoof-voxrmZcZU4wXbE9Hl4UTxM1C7Z2PI9n7-7OEnyIqPrjIninZ6aNVdrJfJHySrjQqWSMf44WVFKy5TxnD9Nzr2_pZRJqvhZcsaUjB-LVfLnxo0BjSUfjG2N3ZGxI19nY8d-tKjBNePhrjeabLRp_Zpst2vynnyfUAcHPan2YHfoyWhJ2CPZ2oAOdDDxHT1V1BxAG_uWfIbetOawiAjYltyYCYc4XEa_TdiTq3kA-y_9BoFs-mYejPXPkicd9B6fL_dF8vPj5Y_qKr3-8mlbba5TLUSZp41qBTChNIOSdYiMqUKropNcllwIpJK1JWraFBnlTYk0b3nBu6bNpeQgG36RvD55Jzf-mtGHejBeY9-DxXH2tSozKmjO_wtmkhdZXuQRfHMCtRu9d9jVkzMDuLs6o_WxujpWV3NVx-oi_HKxzs2A7T26dBXzV0sOXkPfObDa-AdjmSspWBa56sTd-gA7vAfABaN7PK7MSlkc1_LTEbc_pHtwNVr-F1VvuQM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15381686</pqid></control><display><type>article</type><title>Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>IZUMI, Taro ; NAGAYAMA, Takako ; KITAGAWA, Takayasu</creator><creatorcontrib>IZUMI, Taro ; NAGAYAMA, Takako ; KITAGAWA, Takayasu</creatorcontrib><description>The interaction of cinoxacin (CINX), nalidixic acid (NA), and pipemidic acid (PPA) with human and rat serum albumins (HSA and RSA) was studied by UV difference absorption and circular dichroism (CD) spectroscopy. CINX and NA bound to the albumins and generated difference absorption and induced CD (ICD) spectra. The difference absorption spectral data explained reasonably our previous observations that CINX bound to HSA more weakly than NA, but to RSA as strongly as NA. We used a quantity Δε/ε, designated as relative molar difference absorbance, at positions corresponding to the longest wavelength peaks in the difference spectra. The quantity was found to correlate linearly with percent bound to both HSA and RSA, but with different slopes, from which the binding site for CINX and NA in RSA was supposed to provide a much more nonpolar environment than that in HSA. The magnitude of ICD bands observed at 371 nm for CINX and at 342-348 nm for NA corresponded to the binding degrees of these drugs to both albumins. Anisotropy factors for the ICD bands at 350-271 nm for CINX and 320-348 nm for NA were approximately similar between HSA and RSA, suggesting a similar ability to generate the ICD spectra in these wavelength regions upon binding to the albumins. Spectral results for PPA in albumin solutions showed little or no binding of this drug to HSA and RSA. PPA existed as a betaine form in neutral solution and its positively charged group acted as an unfavorable factor for binding to both albumins.</description><identifier>ISSN: 0009-2363</identifier><identifier>EISSN: 1347-5223</identifier><identifier>DOI: 10.1248/cpb.37.746</identifier><identifier>PMID: 2752488</identifier><identifier>CODEN: CPBTAL</identifier><language>eng</language><publisher>Tokyo: The Pharmaceutical Society of Japan</publisher><subject>Animals ; anisotropy factor ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; betaine ; Biological and medical sciences ; cinoxacin ; Cinoxacin - blood ; human albumin ; Humans ; induced CD ; Medical sciences ; nalidixic acid ; Nalidixic Acid - blood ; Nicotinic Acids - blood ; Pharmacology. Drug treatments ; pipemidic acid ; Pipemidic Acid - blood ; protein binding ; Pyridazines - blood ; quinolonecarboxylic acids ; rat albumin ; Rats ; relative difference absorbance ; Serum Albumin - metabolism ; Spectrophotometry, Ultraviolet ; Spectrum Analysis</subject><ispartof>Chemical and Pharmaceutical Bulletin, 1989/03/25, Vol.37(3), pp.746-752</ispartof><rights>The Pharmaceutical Society of Japan</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4496-b7d4a247c2a92fee2278c78f5359344e052d9ec0b8103b9e06d383fbd6553a5b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,1879,4012,27906,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19675421$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2752488$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>IZUMI, Taro</creatorcontrib><creatorcontrib>NAGAYAMA, Takako</creatorcontrib><creatorcontrib>KITAGAWA, Takayasu</creatorcontrib><title>Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins</title><title>Chemical &amp; pharmaceutical bulletin</title><addtitle>Chem. Pharm. Bull.</addtitle><description>The interaction of cinoxacin (CINX), nalidixic acid (NA), and pipemidic acid (PPA) with human and rat serum albumins (HSA and RSA) was studied by UV difference absorption and circular dichroism (CD) spectroscopy. CINX and NA bound to the albumins and generated difference absorption and induced CD (ICD) spectra. The difference absorption spectral data explained reasonably our previous observations that CINX bound to HSA more weakly than NA, but to RSA as strongly as NA. We used a quantity Δε/ε, designated as relative molar difference absorbance, at positions corresponding to the longest wavelength peaks in the difference spectra. The quantity was found to correlate linearly with percent bound to both HSA and RSA, but with different slopes, from which the binding site for CINX and NA in RSA was supposed to provide a much more nonpolar environment than that in HSA. The magnitude of ICD bands observed at 371 nm for CINX and at 342-348 nm for NA corresponded to the binding degrees of these drugs to both albumins. Anisotropy factors for the ICD bands at 350-271 nm for CINX and 320-348 nm for NA were approximately similar between HSA and RSA, suggesting a similar ability to generate the ICD spectra in these wavelength regions upon binding to the albumins. Spectral results for PPA in albumin solutions showed little or no binding of this drug to HSA and RSA. PPA existed as a betaine form in neutral solution and its positively charged group acted as an unfavorable factor for binding to both albumins.</description><subject>Animals</subject><subject>anisotropy factor</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>betaine</subject><subject>Biological and medical sciences</subject><subject>cinoxacin</subject><subject>Cinoxacin - blood</subject><subject>human albumin</subject><subject>Humans</subject><subject>induced CD</subject><subject>Medical sciences</subject><subject>nalidixic acid</subject><subject>Nalidixic Acid - blood</subject><subject>Nicotinic Acids - blood</subject><subject>Pharmacology. Drug treatments</subject><subject>pipemidic acid</subject><subject>Pipemidic Acid - blood</subject><subject>protein binding</subject><subject>Pyridazines - blood</subject><subject>quinolonecarboxylic acids</subject><subject>rat albumin</subject><subject>Rats</subject><subject>relative difference absorbance</subject><subject>Serum Albumin - metabolism</subject><subject>Spectrophotometry, Ultraviolet</subject><subject>Spectrum Analysis</subject><issn>0009-2363</issn><issn>1347-5223</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhSMEKtPChj2SN7BAZHD8EyfshqjQkSoof-voxrmZcZU4wXbE9Hl4UTxM1C7Z2PI9n7-7OEnyIqPrjIninZ6aNVdrJfJHySrjQqWSMf44WVFKy5TxnD9Nzr2_pZRJqvhZcsaUjB-LVfLnxo0BjSUfjG2N3ZGxI19nY8d-tKjBNePhrjeabLRp_Zpst2vynnyfUAcHPan2YHfoyWhJ2CPZ2oAOdDDxHT1V1BxAG_uWfIbetOawiAjYltyYCYc4XEa_TdiTq3kA-y_9BoFs-mYejPXPkicd9B6fL_dF8vPj5Y_qKr3-8mlbba5TLUSZp41qBTChNIOSdYiMqUKropNcllwIpJK1JWraFBnlTYk0b3nBu6bNpeQgG36RvD55Jzf-mtGHejBeY9-DxXH2tSozKmjO_wtmkhdZXuQRfHMCtRu9d9jVkzMDuLs6o_WxujpWV3NVx-oi_HKxzs2A7T26dBXzV0sOXkPfObDa-AdjmSspWBa56sTd-gA7vAfABaN7PK7MSlkc1_LTEbc_pHtwNVr-F1VvuQM</recordid><startdate>1989</startdate><enddate>1989</enddate><creator>IZUMI, Taro</creator><creator>NAGAYAMA, Takako</creator><creator>KITAGAWA, Takayasu</creator><general>The Pharmaceutical Society of Japan</general><general>Maruzen</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M81</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>1989</creationdate><title>Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins</title><author>IZUMI, Taro ; NAGAYAMA, Takako ; KITAGAWA, Takayasu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4496-b7d4a247c2a92fee2278c78f5359344e052d9ec0b8103b9e06d383fbd6553a5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Animals</topic><topic>anisotropy factor</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>betaine</topic><topic>Biological and medical sciences</topic><topic>cinoxacin</topic><topic>Cinoxacin - blood</topic><topic>human albumin</topic><topic>Humans</topic><topic>induced CD</topic><topic>Medical sciences</topic><topic>nalidixic acid</topic><topic>Nalidixic Acid - blood</topic><topic>Nicotinic Acids - blood</topic><topic>Pharmacology. Drug treatments</topic><topic>pipemidic acid</topic><topic>Pipemidic Acid - blood</topic><topic>protein binding</topic><topic>Pyridazines - blood</topic><topic>quinolonecarboxylic acids</topic><topic>rat albumin</topic><topic>Rats</topic><topic>relative difference absorbance</topic><topic>Serum Albumin - metabolism</topic><topic>Spectrophotometry, Ultraviolet</topic><topic>Spectrum Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>IZUMI, Taro</creatorcontrib><creatorcontrib>NAGAYAMA, Takako</creatorcontrib><creatorcontrib>KITAGAWA, Takayasu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Chemical &amp; pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>IZUMI, Taro</au><au>NAGAYAMA, Takako</au><au>KITAGAWA, Takayasu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins</atitle><jtitle>Chemical &amp; pharmaceutical bulletin</jtitle><addtitle>Chem. Pharm. Bull.</addtitle><date>1989</date><risdate>1989</risdate><volume>37</volume><issue>3</issue><spage>746</spage><epage>752</epage><pages>746-752</pages><issn>0009-2363</issn><eissn>1347-5223</eissn><coden>CPBTAL</coden><abstract>The interaction of cinoxacin (CINX), nalidixic acid (NA), and pipemidic acid (PPA) with human and rat serum albumins (HSA and RSA) was studied by UV difference absorption and circular dichroism (CD) spectroscopy. CINX and NA bound to the albumins and generated difference absorption and induced CD (ICD) spectra. The difference absorption spectral data explained reasonably our previous observations that CINX bound to HSA more weakly than NA, but to RSA as strongly as NA. We used a quantity Δε/ε, designated as relative molar difference absorbance, at positions corresponding to the longest wavelength peaks in the difference spectra. The quantity was found to correlate linearly with percent bound to both HSA and RSA, but with different slopes, from which the binding site for CINX and NA in RSA was supposed to provide a much more nonpolar environment than that in HSA. The magnitude of ICD bands observed at 371 nm for CINX and at 342-348 nm for NA corresponded to the binding degrees of these drugs to both albumins. Anisotropy factors for the ICD bands at 350-271 nm for CINX and 320-348 nm for NA were approximately similar between HSA and RSA, suggesting a similar ability to generate the ICD spectra in these wavelength regions upon binding to the albumins. Spectral results for PPA in albumin solutions showed little or no binding of this drug to HSA and RSA. PPA existed as a betaine form in neutral solution and its positively charged group acted as an unfavorable factor for binding to both albumins.</abstract><cop>Tokyo</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>2752488</pmid><doi>10.1248/cpb.37.746</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-2363
ispartof Chemical and Pharmaceutical Bulletin, 1989/03/25, Vol.37(3), pp.746-752
issn 0009-2363
1347-5223
language eng
recordid cdi_proquest_miscellaneous_79104063
source J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry
subjects Animals
anisotropy factor
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
betaine
Biological and medical sciences
cinoxacin
Cinoxacin - blood
human albumin
Humans
induced CD
Medical sciences
nalidixic acid
Nalidixic Acid - blood
Nicotinic Acids - blood
Pharmacology. Drug treatments
pipemidic acid
Pipemidic Acid - blood
protein binding
Pyridazines - blood
quinolonecarboxylic acids
rat albumin
Rats
relative difference absorbance
Serum Albumin - metabolism
Spectrophotometry, Ultraviolet
Spectrum Analysis
title Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T23%3A15%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protein%20Binding%20of%20Quinolonecarboxylic%20Acids.%20II.%20:%20Spectral%20Changes%20on%20the%20Interaction%20of%20Cinoxacin,%20Nalidixic%20Acid%20and%20Pipemidic%20Acid%20with%20Human%20and%20Rat%20Albumins&rft.jtitle=Chemical%20&%20pharmaceutical%20bulletin&rft.au=IZUMI,%20Taro&rft.date=1989&rft.volume=37&rft.issue=3&rft.spage=746&rft.epage=752&rft.pages=746-752&rft.issn=0009-2363&rft.eissn=1347-5223&rft.coden=CPBTAL&rft_id=info:doi/10.1248/cpb.37.746&rft_dat=%3Cproquest_cross%3E79104063%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15381686&rft_id=info:pmid/2752488&rfr_iscdi=true